Business · 18/07/2018Updated: 10/17/2026 · 1 min read
FDA Announces Public Comment Period for Proposed Drug Registration and Listing Collection
Summary
The Food and Drug Administration (FDA) is seeking public input on its proposed collection of information related to drug establishment registration and product listing, as required by the Paperwork Reduction Act of 1995.
Original source language: Federal Register — Food and Drug AdministrationOpen original release →